@article {Abraham645, author = {Sushil Abraham and David Bain and John Bowers and Heidi Kenty and Victor Larivee and Francisco Leira and Jasmina Xie and Jonathan Tsang}, title = {Overview of Best Practices for Biopharmaceutical Technology Transfers}, volume = {69}, number = {5}, pages = {645--649}, year = {2015}, doi = {10.5731/pdajpst.2015.01086}, publisher = {Parenteral Drug Association (PDA)}, abstract = {Technology transfer is a key foundational component in product commercialization. It is more than just the transfer of documents; it relates to all aspects of the transfer of knowledge and experience to the commercial manufacturing unit to ensure consistent, safe, and high-quality product. This is the first in a series of articles from the BioPhorum Operations Group (BPOG) member companies discussing best practices and benchmarking of biopharmaceutical technology transfer. In this article, we provide the common terminology developed by BPOG to accommodate both transferring and receiving organizations. We also review the key elements of a robust technology transfer business process, including critical milestones. Finally, we provide a brief overview of the articles in this series.}, issn = {0006-3363}, URL = {https://journal.pda.org/content/69/5/645}, eprint = {https://journal.pda.org/content/69/5/645.full.pdf}, journal = {PDA Journal of Pharmaceutical Science and Technology} }